Dáil Éireann Debate, Wednesday - 26 July 2017
655. Deputy Billy Kelleher asked the Minister for Health the status of the provision of Vimizin (elosulfase alfa) for the treatment of Morquio A syndrome (MPS 1VA); and if he will make a statement on the matter. [34924/17]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
